Ocular Therapeutix (OCUL) Operating Margin (2016 - 2025)
Historic Operating Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 526.49%.
- Ocular Therapeutix's Operating Margin fell 2304100.0% to 526.49% in Q4 2025 from the same period last year, while for Dec 2025 it was 519.75%, marking a year-over-year decrease of 2501700.0%. This contributed to the annual value of 519.75% for FY2025, which is 2501800.0% down from last year.
- According to the latest figures from Q4 2025, Ocular Therapeutix's Operating Margin is 526.49%, which was down 2304100.0% from 472.35% recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Operating Margin registered a high of 127.41% during Q3 2023, and its lowest value of 597.47% during Q1 2025.
- Over the past 5 years, Ocular Therapeutix's median Operating Margin value was 176.35% (recorded in 2022), while the average stood at 255.5%.
- As far as peak fluctuations go, Ocular Therapeutix's Operating Margin soared by 9671900bps in 2021, and later crashed by -3834600bps in 2025.
- Quarter analysis of 5 years shows Ocular Therapeutix's Operating Margin stood at 146.64% in 2021, then increased by 6bps to 137.56% in 2022, then increased by 2bps to 135.46% in 2023, then plummeted by -119bps to 296.08% in 2024, then crashed by -78bps to 526.49% in 2025.
- Its Operating Margin stands at 526.49% for Q4 2025, versus 472.35% for Q3 2025 and 502.57% for Q2 2025.